FDA.reportPublic FDA data

NDC 72162-1940-01 - Hyoscyamine Sulfate

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
72162-1940
Requested NDC
72162-1940-01
Package NDCs from labels
72162-1940-1, 72162-1940-01
Manufacturer
Bryant Ranch Prepack
Effective date
2023-08-28
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Hyoscyamine Sulfate - Bryant Ranch PrepackBryant Ranch Prepack2023-08-28HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72162-1940-1Hyoscyamine Sulfate100 in 1 BOTTLETABLET100100

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72162-1940HYOSCYAMINE SULFATE TABLET [BRYANT RANCH PREPACK]100Current NDC, 1 package rows20230901_db2dc70e-b2ae-4d65-9c2d-ed4bdfb3c0e7.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
72162-1940-1EA - Each72162-19400a66c84f-3dab-4cd5-bd69-e9288d18cc5a12023-10-16

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 5 · 84 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Hyoscyamine Sulfate TABHYOSCYAMINE SULFATEQPharma, Inc.fc7566e6-c043-fcd4-e053-6294a90a77e52025-12-16Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
QR PAINANALGESICMARYHELENE ENTERPRISES INC8f8f53e3-fe31-e7b5-e053-2995a90a710d2025-11-14WarningsExact identifier
unii: 3OWL53L36A
QR PAINANALGESICMARYHELENE ENTERPRISES INC9984a510-30be-4013-e053-2995a90a841e2025-11-14WarningsExact identifier
unii: 3OWL53L36A
MannitolMANNITOLProPharma Distribution430669d7-9ad1-9a04-e063-6394a90ababb2025-11-07Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
Sorbitol-MannitolSORBITOL AND MANNITOLICU Medical Inc.5b44e248-4b7b-4777-954a-921c7b3099442025-10-30Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
Uro-MPMETHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATEMethod Pharmaceuticals, LLC1e1b0dee-1a3b-4846-a212-c9febb3fc17d2025-10-29Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
MannitolMANNITOLICU Medical Inc.ba7bf864-8a4d-4262-8fd1-00174fa2f9d12025-10-24Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
OSCIMINHYOSCYAMINE SULFATELarken Laboratories, Inc.8504adad-f6d0-4671-b655-4b62bf29a5162025-10-21Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
Hyoscyamine Sulfate ODTHYOSCYAMINE SULFATEAcella Pharmaceuticals, LLCeef6babc-241f-40b6-b8c8-daa92bbd0a252025-10-21Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
Hyoscyamine SulfateHYOSCYAMINE SULFATELaser Pharmaceuticals, LLCb12f856f-7157-4aee-bf73-1fdcb4834ffc2025-10-17Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
OSCIMINHYOSCYAMINE SULFATELarken Laboratories, Inc.2d5fa637-0696-40fe-9bc1-fcb6f07a50f62025-10-16Warnings, Adverse reactionsExact identifier
rxcui: 1046982
unii: F2R8V82B84
Hyoscyamine Sulfate SLHYOSCYAMINE SULFATEAcella Pharmaceuticals, LLC8aab1dce-0699-4866-8707-33b4e2177bdd2025-10-02Warnings, Adverse reactionsExact identifier
rxcui: 1046982
unii: F2R8V82B84
Hyoscyamine Sulfate TABHYOSCYAMINE SULFATEAcella Pharmaceuticals, LLC49fe1783-ab0c-4adb-869b-384121cf7f052025-10-02Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
Hyoscyamine SulfateHYOSCYAMINE SULFATEANI Pharmaceuticals, Inc.3859133e-88bd-4dd5-90a0-82b64347f1db2025-09-12Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
Hyoscyamine SulfateHYOSCYAMINE SULFATEANI Pharmaceuticals, Inc.48fa3d71-8c78-4f29-b1f0-ecac8c36473e2025-09-12Warnings, Adverse reactionsExact identifier
rxcui: 1046982
unii: F2R8V82B84
Hyoscyamine SulfateHYOSCYAMINE SULFATEANI Pharmaceuticals, Inc.cdb8f10a-b426-448f-8991-7724ffa88cb52025-09-12Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
Hyoscyamine SulfateHYOSCYAMINE SULFATEANI Pharmaceuticals, Inc.66fdfc33-a7b9-465b-84f1-012cdf5517fd2025-09-12Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
OsmitrolMANNITOLBaxter Healthcare Company0d914965-7001-45cb-ba51-d7c5964b05bc2025-08-26Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
UROGESIC BLUEMETHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATEEDWARDS PHARMACEUTICALS, INC.d820e42d-ad2b-4e11-907b-a94d698ca2852025-08-13Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84
LevsinHYOSCYAMINE SULFATEViatris Specialty LLC32388e18-08de-455c-aad4-9c2264435f0f2025-07-15Warnings, Adverse reactionsExact identifier
unii: F2R8V82B84

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.